Ind-Swift Laboratories share news and announcements
NSE: INDSWFTLABBSE: 532305Pharmaceuticals & BiotechnologySmall Cap
Last close ₹327.45down ₹17.90 (5.18%)BSE ₹327.80
Share price at the NSE close on 23 Oct 2026. Previous close ₹345.35.
52-week range of traded prices to 23 Oct 2026
₹87.15Low, 31 Dec 2025₹424.75High, 30 Sep 2026
- Under NSE's long-term additional surveillance, stage I, on the list for 23 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Next results date: the board meets on 29 Oct 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹2,848 Cr1,404th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 10 Aug 2026
- 49.7
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹11 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 41.5
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 28 May 2026
- 2.1
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 10 Aug 2026
- 4.5%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹11 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 5.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 10 Aug 2026
- 2.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 28 May 2026
- 0.01
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 6,58,24852.8% delivered
Ind-Swift Laboratories orders, deals and press releases
55 filed, newest first. Page 1 of 2.
Sep 2026
Aug 2026
12 Aug · Business
Jul 2026
May 2026
Feb 2026
Jan 2026
Nov 2025
Aug 2025
Jul 2025
31 Jul · Business
28 Jul · Business
May 2025
Feb 2025
Jan 2025
Nov 2024
Aug 2024
May 2024
18 May · Business
Apr 2024
Nov 2023
Sep 2023
May 2023
Mar 2023
30 Mar · Business
Jan 2023
31 Jan · Business
Feb 2022
8 Feb · Business
Aug 2021
Jun 2020
May 2020
Mar 2020
Jun 2018
Jul 2012
Apr 2012
19 Apr · Business
Board of Directors in its meeting held on April 19, 2012 approved the allotment of 13,15,000 equity shares as under :(1) 13,15,000 equity shares allotted to Promoters Group Companies upon conversion of 13,15,000 Zero Coupon Optionally Convertible Warrants (2010 Series) at a price of Rs. 82.50/- per share.
Feb 2012
Sep 2011
May 2011
26 May · Business
Board of Directors of the Company at its meeting held on May 25, 2011 has allotted 222400 equity shares to the employees of the Company under Employees Stock Option Scheme 2006 at a price of Rs.27/- per share.
Mar 2011
15 Mar · Business
Board of Directors have in its meeting held on March 15, 2011 approved the allotment of 21,20,000 equity shares as under: 1) 5,35,000 equity shares allotted to Promoters Group upon conversion of 535000 Zero Coupon Optionally Convertible Warrants (2009 Series) at a price of Rs. 50/- per share. 2) 4,85,000 equity shares allotted to Promoters Group upon conversion of 4,85,000 Zero Coupon Optionally Convertible Warrants (2010 Series) at a price of Rs. 82.50/- per share. 3) 11,00,000 equity shares allotted to Other Bodies Corporate upon conversion of 11,00,000 Zero Coupon Optionally Convertible Warrants (2010 Series) at a price of Rs. 82.50/- per share.